APA
Saiag P., Gutzmer R., Ascierto P. A., Maio M., Grob J., Murawa P., Dreno B., Ross M., Weber J., Hauschild A., Rutkowski P., Testori A., Levchenko E., Enk A., Misery L., Vanden Abeele C., Vojtek I., Peeters O., Brichard V. G. & Therasse P. (20171222). Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT). : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Saiag P, Gutzmer R, Ascierto P A, Maio M, Grob J-J, Murawa P, Dreno B, Ross M, Weber J, Hauschild A, Rutkowski P, Testori A, Levchenko E, Enk A, Misery L, Vanden Abeele C, Vojtek I, Peeters O, Brichard V G and Therasse P. 20171222. Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT). : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Saiag P., Gutzmer R., Ascierto P. A., Maio M., Grob J., Murawa P., Dreno B., Ross M., Weber J., Hauschild A., Rutkowski P., Testori A., Levchenko E., Enk A., Misery L., Vanden Abeele C., Vojtek I., Peeters O., Brichard V. G. and Therasse P. (20171222). Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT). : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Saiag P, Gutzmer R, Ascierto P A, Maio M, Grob J-J, Murawa P, Dreno B, Ross M, Weber J, Hauschild A, Rutkowski P, Testori A, Levchenko E, Enk A, Misery L, Vanden Abeele C, Vojtek I, Peeters O, Brichard V G and Therasse P. Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT). : Annals of oncology : official journal of the European Society for Medical Oncology. 20171222.